既往免疫经治的晚期非小细胞肺癌患者接受安罗替尼联合PD⁃1单抗的疗效及安全性
武阳 陆翰杰 水会锋
The efficacy and safety of anlotinib plus PD⁃1 blockades in patients with advanced non⁃small cell lung can⁃ cer previously treated with immunotherapy
WU Yang, LU Hanjie, SHUI Huifeng.
实用医学杂志
.
2023, (5): 572
-578
.
DOI: 10.3969/j.issn.1006⁃5725.2023.05.008
